tanshinones in management of oral submucous fibrosis and oral squamous cell carcinoma
Clicks: 190
ID: 128305
2017
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Oral submucous fibrosis is a premalignant condition predominantly occurring in Southeast Asian countries. Oral squamous cell carcinoma is the most common type of oral cancer. The current article highlights the promising benefits of the novel agent tanshinones (TSNs) in the management of oral submucous fibrosis and oral squamous cell carcinoma. The letter is written with the aim to promote more research on TSNs in the management of oral submucous fibrosis and oral squamous cell carcinoma.| Reference Key |
shanbhag2017oncobiologytanshinones
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Vagish Kumar L Shanbhag |
| Journal | oncobiology and targets |
| Year | 2017 |
| DOI | 10.18639/ONBT.2017.04.456966 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.